Advertisement

Prevention and Tocolytic Agent: Hydration, Bed Rest, Ritodrine, and Special Comments on Long-Term Tocolysis

  • Yoshio Matsuda
Chapter
Part of the Comprehensive Gynecology and Obstetrics book series (CGO)

Abstract

Although the diagnosis of preterm labor (PTL) is not always easy, the treatment option of PTL depends on gestational age at diagnosis, degree of emergency (genital bleeding, cervical dilatation, and the presence of painful uterine contraction), need for maternal transfer, and so on.

Keywords

Ritodrine Long-term tocolysis Short-term tocolysis Bed rest 

References

  1. 1.
    Stan CM, Boulvain M, Pfister R, Hirsbrunner-Almagbaly P. Hydration for treatment of preterm labour. Cochrane Database Syst Rev. 2002;(2):CD003096.  https://doi.org/10.1002/14651858.CD003096.
  2. 2.
    Kovacevich GJ, Gaich SA, Lavin JP, Hopkins MP, Crane SS, Stewart J, et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am J Obstet Gynecol. 2000;182:1089–92.CrossRefGoogle Scholar
  3. 3.
    Sosa C, Althabe F, Belizan JM, Bergel E. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev. 2004;(1):CD003581.  https://doi.org/10.1002/14651858.CD003581.pub2.
  4. 4.
    Kaji T, Yasui T, Suto M, Mitani R, Morine M, Uemura H. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women. Bone. 2007;40:1088–94.CrossRefGoogle Scholar
  5. 5.
    Maloni JA. Antepartum bed rest for pregnancy complications: efficacy and safety for preventing preterm birth. Biol Res Nurs. 2010;12:106–24.CrossRefGoogle Scholar
  6. 6.
    Levin HI, Sciscione A, Ananth CV, Drassinower D, Obican SG, Wapner RJ. Activity restriction and risk of preterm delivery. J Matern Fetal Neonatal Med. 2017;2:1–17.  https://doi.org/10.1080/14767058.2017.1337738.CrossRefGoogle Scholar
  7. 7.
    Matsuda M, Ikenoue T, Hokanishi H. Premature rupture of the membranes- aggressive versus conservative approach: effect of tocolytic and antibiotic treatment. Gynecol Obstet Investig. 1993;36:102–10.CrossRefGoogle Scholar
  8. 8.
    Matsuda Y, Maeda Y, Ito M, Sakamoto H, Masaoka N, Takada M, Sato K. Effects of magnesium sulfate treatment on neonatal bone abnormalities. Gynecol Obstet Investig. 1997;44:82–8.CrossRefGoogle Scholar
  9. 9.
    Haram K, Mortensen JHS, Morrison JC. Tocolysis for acute preterm labor: does anything? J Matern Fetal Neonatal Med. 2015;28(4):371–8.CrossRefGoogle Scholar
  10. 10.
    Serov VN, Tyutyunnik VL. Treatment of threatening preterm birth. Reprod Endocrinol. 2012;5:22–4.CrossRefGoogle Scholar
  11. 11.
    Salim R, Garmi G, Nachum Z, Zafran N, Baram S, Shalev E. Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial. Obstet Gynecol. 2012;120(6):1323–31.CrossRefGoogle Scholar
  12. 12.
    Burillo PI, Santana EB, Clemente LO, Duaso MT, Gonzalez EF. Treatment of premature labour. In: Carrera JM, editor. Recommendations and guidelines for perinatal medicine. Barcelona: Matrus Mundi; 2007. p. 230–6.Google Scholar
  13. 13.
    Iams JD. Prevention and management of preterm birth. In: Zuspan FP, Quilligan EJ, editors. Current therapy in obstetrics and gynecology. 4th ed. Philadelphia: W. B. Saunders; 1994. p. 283.Google Scholar
  14. 14.
    Management of Preterm Labor ACOG Practice Bulletin. Obstet Gynecol. 2016;128(4):e155–64.CrossRefGoogle Scholar
  15. 15.
    Shennan AH. Recent developments in obstetrics. BMJ. 2003;327(7415):604–8.CrossRefGoogle Scholar
  16. 16.
    Di Renzo GC, Cabero Roura L, Facchinetti F, Helmer H, Hubinont C, Jacobsson B, et al. Preterm labor and birth management: recommendation from the European Association of Perinatal Medicine. J Matern Fetal Neonatal Med. 2017;30(17):2011–30.CrossRefGoogle Scholar
  17. 17.
    Pisani RJ, Rosenow EC. Pulmonary edema associated with tocolytic therapy. Ann Intern Med. 1989;110:714–6.CrossRefGoogle Scholar
  18. 18.
    Hadi HA, Albazzaz SJ. Cardiac isoenzymes and electrocardiographic changes during ritodrine tocolysis. Am J Obstet Gynecol. 1989;161:318–22.CrossRefGoogle Scholar
  19. 19.
    Minakami H, Takahashi T, Izumi A, Itoi H, Tamada T. Enlargement of the salivary gland after ritodrine treatment in pregnant women. Br Med J. 1992;304:1668–71.CrossRefGoogle Scholar
  20. 20.
    Yasuda R, Makino Y, Matsuda M, Kawamichi Y, Matsui H. Agranulocytosis associated with intravenous ritodrine hydrochloride therapy: two case reports by different mechanisms. J Obstet Gynaecol Res. 2012;38(3):574–7.CrossRefGoogle Scholar
  21. 21.
    WHO. Rhabdomyolysis and ritodrine. 1998:WHO Drug Information: 12 4:239.Google Scholar
  22. 22.
    Matsuda Y, Nagayoshi Y, Kirihara N. Rhabdomyolysis during prolonged intravenous tocolytic therapy: case report. J Perinat Med. 2002;30:514–6.PubMedGoogle Scholar
  23. 23.
    Matsuda Y, Nagayoshi Y, Kirihara N. Evaluation of creatine kinase level during long-term tocolysis. J Perinat Med. 2002;30:476–9.PubMedGoogle Scholar
  24. 24.
    Navathe R, Berghella V. Tocolysis for acute preterm labor: where have we been, where are we now, and where are we going? Am J Perinatol. 2016;33:229–35.CrossRefGoogle Scholar
  25. 25.
    US Food and Drug Administration. FDA drug safety communication: new warnings against use of terbutaline to treat preterm labor. Silver Spring: FDA; 2011.Google Scholar
  26. 26.
    Hill WC, Katz M, Kitzmiiier JL, Gill PJ. Continuous long-term intravenous β-sympathomimetic tocolysis. Am J Obstet Gynecol. 1985;152:271–4.CrossRefGoogle Scholar
  27. 27.
    Dudley D, Gagnon D, Varmer M. Long-term tocolysis with intravenous magnesium sulfate. Obstet Gynecol. 1989;73:373–8.PubMedGoogle Scholar
  28. 28.
    Takagi K, Satoh K, Matsuda Y, Multicentre Premature Labour Study Group. Is long-term tocolysis effective for threatened premature labour? J Int Med Res. 2009;37:227–39.CrossRefGoogle Scholar
  29. 29.
    Nakamura M, Hasegawa J, Arakaki T, Hamada S, Takita H, Oba T, Koide K, Matsuoka R, Sekizawa A. Comparison of perinatal outcomes between long-term and short-term use of tocolytic agent: a historical cohort study in a single perinatal hospital. J Obstet Gynaecol Res. 2016;42(12):1680–5.CrossRefGoogle Scholar
  30. 30.
    Parets SE, Bedient CE, Menon R, Smith AK. Preterm birth and its long-term effects: methylation to mechanisms. Biology (Basel). 2014;3(3):498–513.Google Scholar
  31. 31.
    Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, NICHD Maternal-Fetal Medicine Units Network, et al. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374:1311–20.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Yoshio Matsuda
    • 1
  1. 1.Japan Community Health care Organization (JCHO), Mishima General HospitalMishimaJapan

Personalised recommendations